Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal of hepatology·2026

Same author

Enhanced Anti-Counterfeiting Using Dynamic Encryption with Dual Physically Unclonable Functions.

ACS applied materials & interfaces·2026

Same author

Structural insights into histone mimicry by the small hepatitis delta antigen.

The Journal of biological chemistry·2026

Same author

Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Magnetic Field-Boosted Pt Utilization in MOFs for Efficient Hydrogen Evolution Reaction.

ACS applied materials & interfaces·2026

Same author

ECM remodeling features in reparative chondrocytes during knee osteoarthritis.

Frontiers in endocrinology·2026

Search research articles

Related Experiment Video

Updated: Nov 28, 2025

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Interplay between Hepatitis D Virus and the Interferon Response.

Zhenfeng Zhang¹, Stephan Urban^1,2

¹Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

|November 25, 2020

Summary

This summary is machine-generated.

Chronic hepatitis D (CHD) is severe, rapidly progressing liver disease. Hepatitis D virus (HDV) triggers a strong interferon response via MDA5, limiting spread but not replication in resting cells.

Keywords:

Hepcludex Myrcludex B cell-division-mediated spread countermeasures de novo infection hepatitis B virus hepatitis D virus interferon response pattern recognition receptors persistence

More Related Videos

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Related Experiment Videos

Last Updated: Nov 28, 2025

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Area of Science:

Virology
Immunology
Hepatology

Background:

Chronic hepatitis D (CHD) is the most severe viral hepatitis, leading to rapid liver disease progression and hepatocellular carcinoma.
Hepatitis D virus (HDV) relies on hepatitis B virus (HBV) for entry and spread but replicates autonomously.
HDV activates a robust interferon (IFN) response, unlike HBV, primarily through the MDA5 pathway.

Purpose of the Study:

To review current knowledge on HDV structure, replication, and persistence.
To focus on the intricate interplay between HDV and the host's IFN response.
To discuss the crosstalk between HDV and HBV infections.

Main Methods:

Review of existing literature on HDV and IFN pathways.
Analysis of HDV's interaction with cellular innate immune sensors like MDA5.
Examination of viral countermeasures against IFN-mediated immunity.

Main Results:

HDV induces a potent IFN response via MDA5, which inhibits cell-division-mediated spread and early infection.
This IFN response has a limited effect on HDV RNA replication in resting hepatocytes.
HDV can amplify HBV replication independently.

Conclusions:

The HDV-IFN interaction is a critical factor in disease progression and viral persistence.
Understanding this interplay is key to developing therapeutic strategies for CHD.
Further research into HDV-HBV crosstalk may reveal novel treatment targets.